ALPS Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
ALPS Advisors's NVAX Position: Q3 2026 in Review
ALPS Advisors sold out of Novavax (NVAX) in Q3 2026, closing a stake of 48,989 shares — an estimated $461K sold.
ALPS Advisors first reported a position in NVAX in Q2 2022 and held it in 11 quarters. The position peaked at $2.38M in Q2 2022. 262 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- ALPS Advisors reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
- ALPS Advisors sold 48,989 Novavax shares in Q3 2026, an estimated $461K.
- ALPS Advisors first reported a position in Novavax in Q2 2022 and held it in 11 quarters.
- ALPS Advisors's Novavax position peaked at $2.38M in Q2 2022.
- 262 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.